Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Non-Current Liabilities (2020 - 2024)

Journey Medical's Total Non-Current Liabilities history spans 5 years, with the latest figure at $60.2 million for Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities rose 6.5% year-over-year to $60.2 million, compared with a TTM value of $60.2 million through Dec 2024, up 6.5%, and an annual FY2024 reading of $60.2 million, up 6.5% over the prior year.
  • Total Non-Current Liabilities for Q4 2024 was $60.2 million at Journey Medical, up from $56.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $97.2 million in Q3 2021, with the low at $33.5 million in Q4 2020.
  • Average Total Non-Current Liabilities over 5 years is $70.2 million, with a median of $74.9 million recorded in 2022.
  • Year-over-year, Total Non-Current Liabilities surged 68.11% in 2022 and then crashed 34.88% in 2023.
  • Tracing DERM's Total Non-Current Liabilities over 5 years: stood at $33.5 million in 2020, then surged by 54.18% to $51.6 million in 2021, then surged by 68.11% to $86.8 million in 2022, then plummeted by 34.88% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024.
  • Per Business Quant, the three most recent readings for DERM's Total Non-Current Liabilities are $60.2 million (Q4 2024), $56.5 million (Q4 2023), and $68.3 million (Q2 2023).